NCT01392027

Brief Summary

This proposed project is designed to collect data and specimens from patients/subjects presenting to the University of Michigan with a disease affecting the pancreas (or specific control populations). This protocol is focused on collecting data, blood samples, and tissue on subjects with pancreatic diseases, including pancreatic cancer, pancreatic cysts, pancreatitis, diabetic controls, jaundice/biliary obstruction controls, and otherwise healthy controls. We are collecting up to 50 mls of blood for research purposes only. Plasma, serum and buffy coat are collected and stored according to strict SOPs.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
712

participants targeted

Target at P75+ for not_applicable pancreatic-cancer

Timeline
Completed

Started Apr 2011

Longer than P75 for not_applicable pancreatic-cancer

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

April 1, 2011

Completed
3 months until next milestone

First Submitted

Initial submission to the registry

July 6, 2011

Completed
6 days until next milestone

First Posted

Study publicly available on registry

July 12, 2011

Completed
6.1 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

August 31, 2017

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

August 31, 2017

Completed
Last Updated

November 8, 2017

Status Verified

November 1, 2017

Enrollment Period

6.4 years

First QC Date

July 6, 2011

Last Update Submit

November 6, 2017

Conditions

Keywords

Pancreatic CancerChronic PancreatitisDiseases of the pancreas

Outcome Measures

Primary Outcomes (1)

  • Validation of glycoprotein panel as a pancreatic cancer biomarker

    To create a set of cases and controls to validate a novel glycoprotein panel for non-invasive or early detection of pancreatic cancer.

    5 years

Interventions

Blood DrawPROCEDURE

Blood draw for research specimens only

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Adults 18 years of age or older
  • Able to physically tolerate removal of 50 ml of blood
  • Willing to sign informed consent.

You may not qualify if:

  • Pregnant or lactating
  • Known HIV/AIDS or Hepatitis C
  • Prepped for colonoscopy at the time of blood collection
  • Unable to understand English
  • Receiving chemotherapy or radiation at time of enrollment
  • Any cancer within 5 years of enrollment except any of the following:
  • Squamous cell carcinoma of the skin or Basal cell carcinoma of the skin
  • Carcinoma in situ of the cervix, Stages Ia or Ib invasive squamous cell carcinoma of the cervix treated by surgery only. (Excluded if had pelvic radiation)
  • Stage Ia Grade 1 adenocarcinoma of the endometrium treated with surgery

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Univerisity of Michigan

Ann Arbor, Michigan, 48109, United States

Location

MeSH Terms

Conditions

Pancreatic NeoplasmsPancreatitis, ChronicDiabetes Mellitus, Type 2Pancreatic CystPancreatic Diseases

Interventions

Blood Specimen Collection

Condition Hierarchy (Ancestors)

Digestive System NeoplasmsNeoplasms by SiteNeoplasmsEndocrine Gland NeoplasmsDigestive System DiseasesEndocrine System DiseasesPancreatitisChronic DiseaseDisease AttributesPathologic ProcessesPathological Conditions, Signs and SymptomsDiabetes MellitusGlucose Metabolism DisordersMetabolic DiseasesNutritional and Metabolic DiseasesCysts

Intervention Hierarchy (Ancestors)

Specimen HandlingClinical Laboratory TechniquesDiagnostic Techniques and ProceduresDiagnosisPuncturesSurgical Procedures, OperativeInvestigative Techniques

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
PREVENTION
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Project manager

Study Record Dates

First Submitted

July 6, 2011

First Posted

July 12, 2011

Study Start

April 1, 2011

Primary Completion

August 31, 2017

Study Completion

August 31, 2017

Last Updated

November 8, 2017

Record last verified: 2017-11

Locations